Methylphenidate transdermal system.
Mays
David A
DA
Findling
Robert
R
D000279:Administration, Cutaneous; D001289:Attention Deficit Disorder with Hyperactivity / Q000175:diagnosis / Q000188:drug therapy*; D000697:Central Nervous System Stimulants / Q000008:administration & dosage* / Q000009:adverse effects; D002648:Child; D002986:Clinical Trials as Topic / Q000331:legislation & jurisprudence; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D017277:Drug Approval; D006801:Humans; D008774:Methylphenidate / Q000008:administration & dosage* / Q000009:adverse effects; D014481:United States; D014486:United States Food and Drug Administration
D000697:Central Nervous System Stimulants; D008774:Methylphenidate